Bimzelx
Active substance: bimekizumab
INJECTION, SOLUTION · BIMEKIZUMAB 320 mg/2mL
United StatesActive
Marketing holder: UCB, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- BIMEKIZUMAB · 320 mg/2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-6160-77fc-b2c3-f2576ce16f52,01a1208e-6165-7c3e-bf8f-10ddbfa5f433,01a12096-047b-7271-84df-199f9f2fa52c,01a1209b-1193-7b7a-ae82-f2cf7f47b177;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50474-783
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 50474-783 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50474-783 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50474-783 · Verified 2026-10-09 · open in source